Article Details

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

Retrieved on: 2021-06-21 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19. View article details on hiswai:

Excerpt

... room air by Day 14 for patients on opaganib was maintained regardless of whether the patients were receiving dexamethasone and/or remdesivir.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo